Austrianova is one company that does businesses that comprises high tech, life sciences and biotech.
It is complemented with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science based organization that focuses in the enclosure of living cells or bacteria in small tablets for protection which is also known as cell encapsulation technology, isolation, storage and transportation. We were first established in the year 2007 and was built in Singapore's best study biotech hub, Biopolis that has global footprint in providing encapsulation facilities like micro encapsulation.
There is a quick growing area of passion in healthy attention and more precise, in the topic of neutraceuticals which is the teaching and use of probiotic bacteria. Therefore, probiotics encapsulation was developed. The cell-in-a-box technology was created by Austranova with the target to guard, separate, store and transfer living cells. This advanced technology can be used for many purposes and can be used to probiotics, cosmetics and agriculture environmental protection and screening as well as forming the base of a influential study instrument.
In healthcare, this knowledge helps controloperate secure attaching of cells or stem cells such as cell therapy, involving them isolated from the immune system and enabling long term making of therapeutic molecules in patients. In biotechnology, the cell-in-a-box skill guards cells in bioreactors and fermentors and at the same time, it make simpler cleansing of bioproducts produced from the cells and it lessen production cost too.
A wide rule cGMP facility for the making of biomedical grade encapsulated cell items was beforehand positively constructed and right now, Austrianova is in the process of developing this capability in the whole of SE Asia. This means the use of cell-in-a-box was quite a victory for ancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to allow lesser doses of chemotherapy to be used more effectually without the normal devastating side results. The encapsulated cell are placed, using supraselective catheterisation, into blood vessels that drives to the tumor where they locally switch a chemotherapeutic product to its tumor toxic product.
Come to our website for additional information: Probiotics Encapsulation, GMP Manufacturing, Microbeads.
